Evaluating the Role of IL-17 as an Orchestrator of Peripheral-central Cross Talk in Depressive Symptoms

NCT06786936 · clinicaltrials.gov ↗

RECRUITING

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Psoriatic Arthritis
Depression
Psoriatic Plaque

Interventions

DRUG: Secukinumab
DRUG: Bimekizumab
DRUG: Ixekizumab
DRUG: Placebo

Sponsor

NHS Greater Glasgow and Clyde

Collaborators

[object Object]
[object Object]